Your browser doesn't support javascript.
loading
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.
Mavaddat, Nasim; Dorling, Leila; Carvalho, Sara; Allen, Jamie; González-Neira, Anna; Keeman, Renske; Bolla, Manjeet K; Dennis, Joe; Wang, Qin; Ahearn, Thomas U; Andrulis, Irene L; Beckmann, Matthias W; Behrens, Sabine; Benitez, Javier; Bermisheva, Marina; Blomqvist, Carl; Bogdanova, Natalia V; Bojesen, Stig E; Briceno, Ignacio; Brüning, Thomas; Camp, Nicola J; Campbell, Archie; Castelao, Jose E; Chang-Claude, Jenny; Chanock, Stephen J; Chenevix-Trench, Georgia; Christiansen, Hans; Czene, Kamila; Dörk, Thilo; Eriksson, Mikael; Evans, D Gareth; Fasching, Peter A; Figueroa, Jonine D; Flyger, Henrik; Gabrielson, Marike; Gago-Dominguez, Manuela; Geisler, Jürgen; Giles, Graham G; Guénel, Pascal; Hadjisavvas, Andreas; Hahnen, Eric; Hall, Per; Hamann, Ute; Hartikainen, Jaana M; Hartman, Mikael; Hoppe, Reiner; Howell, Anthony; Jakubowska, Anna; Jung, Audrey; Khusnutdinova, Elza K.
Afiliação
  • Mavaddat N; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, England.
  • Dorling L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, England.
  • Carvalho S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, England.
  • Allen J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, England.
  • González-Neira A; Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, Spain.
  • Keeman R; Division of Molecular Pathology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, England.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, England.
  • Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, England.
  • Ahearn TU; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
  • Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Beckmann MW; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Behrens S; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Benitez J; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Bermisheva M; Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, Spain.
  • Blomqvist C; Biomedical Network on Rare Diseases, Madrid, Spain.
  • Bogdanova NV; Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
  • Bojesen SE; Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Briceno I; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
  • Brüning T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Camp NJ; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
  • Campbell A; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Castelao JE; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Chang-Claude J; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Chanock SJ; Medical Faculty, Universidad de La Sabana, Bogota, Colombia.
  • Chenevix-Trench G; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany.
  • Christiansen H; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City.
  • Czene K; Centre for Genomic and Experimental Medicine, Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, Scotland.
  • Dörk T; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland.
  • Eriksson M; Oncology and Genetics Unit, Instituto de Investigación Sanitaria Galicia Sur, Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
  • Evans DG; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Fasching PA; Cancer Epidemiology Group, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Figueroa JD; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
  • Flyger H; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Gabrielson M; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
  • Gago-Dominguez M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Geisler J; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Giles GG; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Guénel P; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, England.
  • Hadjisavvas A; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University National Health Service Foundation Trust, Manchester Academic Health Science Centre, Manchester, England.
  • Hahnen E; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Hall P; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles.
  • Hamann U; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland.
  • Hartikainen JM; Cancer Research UK Edinburgh Centre, University of Edinburgh, Edinburgh, Scotland.
  • Hartman M; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Hoppe R; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Howell A; Fundación Pública Galega de Medicina Xenómica, Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
  • Jakubowska A; Moores Cancer Center, University of California San Diego, La Jolla.
  • Jung A; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.
  • Khusnutdinova EK; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Campus at Akershus University Hospital, Norway.
JAMA Oncol ; 8(3): e216744, 2022 Mar 01.
Article em En | MEDLINE | ID: mdl-35084436
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article